SCHEMBL1634788

SCHEMBL1634788

C#Cc1ccc(OC2CCNCC2)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 6/20 0.44
CHUK O15111 3/20 0.44
AKT1 P31749 1/20 0.44
ROCK1 Q13464 1/20 0.44
JAK2 O60674 1/20 0.44
JAK1 P23458 1/20 0.44
TYK2 P29597 1/20 0.44
JAK3 P52333 1/20 0.44
CDK1 P06493 3/20 0.42
CDK2 P24941 3/20 0.42
CDK7 P50613 3/20 0.42
CDK9 P50750 3/20 0.42
CCNT1 O60563 2/20 0.42
CCNB1 P14635 2/20 0.42
CCNH P51946 2/20 0.42
CA2 P00918 4/20 0.41
CA1 P00915 3/20 0.41
CA9 Q16790 3/20 0.41
CA4 P22748 2/20 0.41
SYK P43405 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632091 0.87 IKBKB (0.47) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1633855 0.86 JAK1 (0.48) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1633531 0.82 IKBKB (0.47) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1633545 0.81 JAK2 (0.65) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1633546 0.78 CDK1 (0.44) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL12764372 0.77 IKBKB (0.48) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1631902 0.77 IKBKB (0.48) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL4059017 0.76 IGF1R (0.51) IKBKBCHUKAKT1ROCK1CDK1
SCHEMBL1634422 0.76 JAK2 (0.58) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1632781 0.76 JAK2 (0.58) IKBKBCHUKAKT1ROCK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed